Alligator Competitors

ATORX-TO-9

0.07 0.02 39.22%

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alligator Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Alligator Bioscience Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Alligator Bioscience and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Alligator and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Alligator Bioscience does not affect the price movement of the other competitor.

	CTM	SHB-B	TRAIN-B	WPTG-B	SEB-C	NIO
CTM		-0.82	-0.22	-0.57	0.66	-0.76	CTM
SHB-B	-0.82		0.34	0.49	-0.19	0.76	SHB-B
TRAIN-B	-0.22	0.34		-0.37	-0.02	0.23	TRAIN-B
WPTG-B	-0.57	0.49	-0.37		-0.37	0.41	WPTG-B
SEB-C	0.66	-0.19	-0.02	-0.37		-0.29	SEB-C
NIO	-0.76	0.76	0.23	0.41	-0.29		NIO
	CTM	SHB-B	TRAIN-B	WPTG-B	SEB-C	NIO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

NIO	+ 0.76	SHB-B
SEB-C	+ 0.66	CTM
WPTG-B	+ 0.49	SHB-B
NIO	+ 0.41	WPTG-B
TRAIN-B	+ 0.34	SHB-B
NIO	+ 0.23	TRAIN-B

High negative correlations

SHB-B	- 0.82	CTM
NIO	- 0.76	CTM
WPTG-B	- 0.57	CTM
SEB-C	- 0.37	WPTG-B
WPTG-B	- 0.37	TRAIN-B
NIO	- 0.29	SEB-C

Risk-Adjusted Indicators

There is a big difference between Alligator Stock performing well and Alligator Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alligator Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CTM	2.75	(0.73)	0.00	(4.89)	0.00	0.00	3.35	(6.33)	23.98
SHB-B	0.84	0.14	0.01	(1.56)	0.80	(1.01)	1.87	(1.33)	8.54
TRAIN-B	0.93	(0.02)	0.00	0.41	0.00	0.00	2.11	(1.97)	6.14
WPTG-B	3.06	0.71	0.20	1.90	2.63	(3.78)	8.00	(5.01)	33.60
SEB-C	0.94	(0.13)	0.00	(0.68)	0.00	0.00	1.60	(1.82)	8.01
NIO	2.34	0.20	0.04	1.03	2.11	(3.46)	6.14	(4.08)	25.71

Unable to evaluate fundamental data of Alligator Bioscience AB at this time. Please try again later

All Fundamental Data

Alligator Bioscience Competitive Analysis

The better you understand Alligator Bioscience competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Alligator Bioscience's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Alligator Bioscience's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	ATORX-TO-9	CTM	SHB-B	TRAIN-B	WPTG-B	SEB-C	NIO
	39.22 0.07 Alligator	3.58 4.31 Catena	0.21 145.70 Svenska	0.53 18.60 Train	0.34 5.96 White	0.52 153.40 Skandinaviska	0.99 5.00 Nordic
Market Volatility (90 Days Market Risk)	Out of control	Relatively risky	Very steady	Very steady	Relatively risky	Very steady	Relatively risky
Market Performance (90 Days Performance)	Insignificant	Very Weak	OK	Very Weak	Good	Very Weak	Insignificant
Odds of Financial Distress (Probability Of Bankruptcy)	Unknown	Low	Average	Low	Unknown	Above Average	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Over Valued	Fairly Valued	Over Valued	Fairly Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Sell	Sell	Cautious Hold	Cautious Hold	Strong Sell
Current Ratio		0.44 X	N/A	6.08 X		N/A	0.77 X
Net Asset		366.17 M	3.45 T	1.57 B		3.53 T	165.77 M
Profit Margin		0.15 %	0.43 %	0.60 %		0.43 %	N/A
EBITDA		9.53 M	32.71 B	38.36 M		N/A	(7.82 M)
Operating Margin		0.31 %	0.54 %	0.71 %		0.56 %	N/A
Current Valuation		2.26 B	1.14 T	2.43 B		470.89 B	307.4 M
Price To Book		0.69 X	1.30 X	1.70 X		1.36 X	2.05 X
Retained Earnings		10 M	115.02 B	N/A		109.32 B	N/A
Current Asset		27 M	471.55 B	N/A		1.19 T	N/A
Five Year Return		N/A	4.51 %	N/A		5.55 %	N/A
Beta		1.26	0.64	0.54		0.87	1.67
Number Of Employees		451	11.17 K	9		16.5 K	3
Shares Outstanding		71.63 M	35.25 M	23.59 M		24.15 M	37.14 M
Cash Flow From Operations		65.8 M	(38.3 B)	(20.61 M)		(70.17 B)	(9.11 M)
Annual Yield		N/A	0.04 %	N/A		0.05 %	N/A
Total Debt		78.48 M	1.39 T	178.26 M		795.15 B	2.1 M
Return On Equity		0.0947	0.11	0.0804		0.14	-0.0652
Z Score		20.4	N/A	7.2		N/A	85.8
Return On Asset		0.0753	0.0062	0.0506		0.0079	-0.0333
Book Value Per Share		3.21 X	99.00 X	53.47 X		96.77 X	3.98 X
Current Liabilities		11 M	1.84 T	N/A		1.49 T	N/A
Total Asset		366.17 M	3.45 T	1.57 B		3.53 T	165.77 M
Debt To Equity		104.10 %	N/A	0.15 %		N/A	8.10 %
Target Price		30.13	110.0	N/A		N/A	N/A
Last Dividend Paid		N/A	5.5	N/A		6.75	N/A
Shares Owned By Institutions		31.38 %	4.54 %	28.10 %		44.59 %	N/A
Market Capitalization		2.68 B	204.71 B	2.3 B		264.05 B	301.04 M
Price To Earning		121.64 X	14.88 X	76.50 X		10.75 X	N/A
Price To Earnings To Growth		N/A	6.95 X	N/A		1.60 X	N/A
Price To Sales		12.16 X	4.28 X	13.04 X		4.40 X	1,798 X
Net Income		(7.17 M)	21.47 B	19.38 M		26.99 B	(8.84 M)
Earnings Per Share		2.72 X	10.70 X	4.10 X		12.55 X	(0.22) X
Shares Owned By Insiders		21.20 %	N/A	53.59 %		0.04 %	54.19 %
Revenue		136.11 M	49.2 B	125.03 M		64.59 B	N/A
Working Capital		16 M	(1.37 T)	N/A		(293.59 B)	N/A
Cash And Equivalents		732 K	639.23 B	154.16 M		482.82 B	2.81 M
Cash Per Share		0.22 X	322.84 X	5.84 X		223.50 X	0.19 X
Gross Profit		89.91 M	50.23 B	46.91 M		62.58 B	120.6 K
Day Typical Price	0.0631	4.37	146.0	18.67	5.92	152.87	5.1
Accumulation Distribution	0.34	1062.18	599.85	77.67	110.21	156.68	1117.25
Market Facilitation Index	0.0238	0.0	0.0	1.0E-4	0.0	1.0E-4	0.0
Daily Balance Of Power	0.8403	(0.84)	(0.23)	(0.25)	0.125	0.5	(0.17)
Period Momentum Indicator	0.02	(0.16)	(0.30)	(0.10)	0.02	0.8	(0.05)
Rate Of Daily Change	1.39	0.96	1.0	0.99	1.0	1.01	0.99
Day Median Price	0.0591	4.4	146.15	18.7	5.9	152.6	5.15
Price Action Indicator	0.0219	(0.18)	(0.60)	(0.15)	0.07	1.2	(0.17)
Relative Strength Index	46.94	22.5	69.16	42.17	72.13	56.73	40.88
Coefficient Of Variation	2176.71	(592.55)	881.38	(9,969)	628.02	(1,232)	1517.73
Mean Deviation	13.95	2.75	0.8395	0.9328	3.06	0.9436	2.34
Jensen Alpha	1.01	(0.73)	0.1447	(0.02)	0.7093	(0.13)	0.2042
Total Risk Alpha	(2.67)	(1.41)	(0.08)	(0.23)	(0.05)	(0.32)	(0.38)
Sortino Ratio	0.0464	N/A	0.0062	N/A	0.1973	N/A	0.0416
Downside Variance	353.85	N/A	0.9854	N/A	10.29	N/A	6.43
Standard Deviation	21.98	4.16	1.27	1.25	4.84	1.26	3.69
Kurtosis	8.87	6.44	10.76	0.8859	13.64	2.43	13.94
Potential Upside	30.0	3.35	1.87	2.11	8.0	1.6	6.14
Treynor Ratio	(17.29)	(4.89)	(1.56)	0.4136	1.9	(0.68)	1.03
Maximum Drawdown	153.35	23.98	8.54	6.14	33.6	8.01	25.71
Variance	482.94	17.33	1.61	1.56	23.41	1.6	13.6
Market Risk Adjusted Performance	(17.28)	(4.88)	(1.55)	0.4236	1.91	(0.67)	1.04
Risk Adjusted Performance	0.0448	(0.12)	0.0907	(0)	0.1301	(0.06)	0.0583
Skewness	2.01	0.0536	2.14	0.2248	2.78	(0.61)	2.87
Semi Deviation	14.59	N/A	0.8007	N/A	2.63	N/A	2.11
Information Ratio	0.0397	(0.20)	0.0049	(0.12)	0.1308	(0.19)	0.0286
Value At Risk	(29.09)	(6.33)	(1.33)	(1.97)	(5.01)	(1.82)	(4.08)
Expected Short fall	(20.99)	N/A	(1.01)	N/A	(3.78)	N/A	(3.46)
Downside Deviation	18.81	N/A	0.9927	N/A	3.21	N/A	2.54
Semi Variance	212.92	N/A	0.6412	N/A	6.94	N/A	4.45

Alligator Bioscience Competition Performance Charts

Five steps to successful analysis of Alligator Bioscience Competition

Alligator Bioscience's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Alligator Bioscience in relation to its competition. Alligator Bioscience's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Alligator Bioscience in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Alligator Bioscience's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Alligator Bioscience, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Alligator Bioscience position

In addition to having Alligator Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Picks Thematic Idea Now

Macroaxis Picks

Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.

View All Next

Launch

Additional Tools for Alligator Stock Analysis

When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC